Search publications

Publications

  • Barroso E, Díaz M, Reguera AC, Peyman M, Balsinde J, Jurado-Aguilar J, Zhang M, Rostami A, Palomer FX, Ibañez-Toda L and Vazquez M.

    CHOP upregulation and dysregulation of the mature form of the SNAT2 amino acid transporter in the placentas from small for gestational age newborns

    CELL COMMUNICATION AND SIGNALING . 21(1): 326-326. Number of citations: 1

    [doi:10.1186/s12964-023-01352-5]

  • Zhang M, Barroso E, Ruart M, Peña L, Peyman M, Aguilar-Recarte D, Montori M, Rada P, Cugat C, Montironi C, Zarei M, Jurado-Aguilar J, Camins A, Balsinde J, Valverde ÁM, Wahli W, Palomer FX and Vazquez M.

    Elafibranor upregulates the EMT-inducer S100A4 via PPARß/d

    BIOMEDICINE & PHARMACOTHERAPY . 167: 115623-115623. Number of citations: 6

    [doi:10.1016/j.biopha.2023.115623]

  • Zhang M, Bagán A, Martínez D, Barroso E, Palomer FX, Vázquez S, Escolano C and Vazquez M.

    Design and Synthesis of AMPK Activators and GDF15 Inducers

    Molecules . 28(14): .

    [doi:10.3390/molecules28145468]

  • Barroso E, Montori M, Wahli W, Palomer FX and Vazquez M.

    Striking a gut-liver balance for the antidiabetic effects of metformin

    TRENDS IN PHARMACOLOGICAL SCIENCES . 44(7): 457-473. Number of citations: 5

    [doi:10.1016/j.tips.2023.04.004]

  • Aguilar-Recarte D, Barroso E, Zhang M, Rada P, Pizarro J, Peña L, Palomer FX, Valverde ÁM, Wahli W and Vazquez M.

    A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.

    PHARMACOLOGICAL RESEARCH . 187: 106578-106578. Number of citations: 19

    [doi:10.1016/j.phrs.2022.106578]

  • Aguilar-Recarte D, Barroso E, Palomer FX, Wahli W and Vazquez M.

    Knocking on GDF15?s door for the treatment of type 2 diabetes mellitus

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 33(11): 741-754. Number of citations: 20

    [doi:10.1016/j.tem.2022.08.004]

  • Montori M, Aguilar-Recarte D, Zarei M, Pizarro J, Palomer FX and Vazquez M.

    Endoplasmic reticulum stress downregulates PGC-1a in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2

    CELL COMMUNICATION AND SIGNALING . 20(1): 53-53. Number of citations: 13

    [doi:10.1186/s12964-022-00865-9]

  • Aguilar-Recarte D, Barroso E, Gumá L, Pizarro J, Peña L, Ruart M, Palomer FX, Wahli W and Vazquez M.

    GDF15 mediates the metabolic effects of PPARß/d by activating AMPK.

    CELL REPORTS . 36(6): 109501-109501. Number of citations: 54

    [doi:10.1016/j.celrep.2021.109501]

  • Aguilar-Recarte D, Palomer FX, Wahli W and Vazquez M.

    The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 22(16): 8555. Number of citations: 20

    [doi:10.3390/ijms22168555]

  • Palomer FX, Aguilar-Recarte D, García R, Nistal JF and Vazquez M.

    Sirtuins: To Be or Not To Be in Diabetic Cardiomyopathy.

    TRENDS IN MOLECULAR MEDICINE . 27(6): 554-571. Number of citations: 29

    [doi:10.1016/j.molmed.2021.03.004]